Early versus Late Intervention Trial with Estradiol

Last updated

The Early versus Late Intervention Trial with Estradiol (ELITE) was a large randomized controlled trial that assessed the timing hypothesis that menopausal hormone therapy in early but not late menopause would improve cardiovascular outcomes. [1] [2]

References

  1. ↑ Hodis HN, Mack WJ, Shoupe D, Azen SP, Stanczyk FZ, Hwang-Levine J, Budoff MJ, Henderson VW (April 2015). "Methods and baseline cardiovascular data from the Early versus Late Intervention Trial with Estradiol testing the menopausal hormone timing hypothesis". Menopause. 22 (4): 391–401. doi:10.1097/GME.0000000000000343. PMC   4376597 . PMID   25380275.
  2. ↑ Pabbidi MR, Kuppusamy M, Didion SP, Sanapureddy P, Reed JT, Sontakke SP (December 2018). "Sex differences in the vascular function and related mechanisms: role of 17β-estradiol". Am. J. Physiol. Heart Circ. Physiol. 315 (6): H1499 –H1518. doi: 10.1152/ajpheart.00194.2018 . PMID   30192631.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.